Esperion Therapeutics logo
Esperion Therapeutics ESPR
$ 2.51 1.42%

Квартальный отчет 2024-Q3
добавлен 07.11.2024

report update icon

Esperion Therapeutics Мультипликаторы 2011-2024 | ESPR

Мультипликаторы по годам Esperion Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.4 -1.6 -0.4 -5.9 -15.2 -6.0 -10.3 -3.3 -6.6 -20.7 -4.9 - -

P/S

2.6 5.1 1.5 3.7 10.0 - - - - - - - -

EPS

-2.0 -3.5 -9.3 -5.2 -3.6 -7.5 -7.0 -3.3 -2.3 -2.2 -3.3 -36.3 -36.2

EV (Enterprise Value)

877 млн 829 млн 488 млн 991 млн 1.51 млрд 1.24 млрд 1.71 млрд 228 млн 259 млн 676 млн 76 млн 18.2 млн 6.67 млн

EBITDA per Share

-1.51 -2.7 -7.82 -4.5 -3.42 -7.64 -7.05 -3.37 -2.26 -2.2 -2.88 - -

EV/EBITDA

-2.1 -6.0 -14.2 -5.7 -10.0 -2.8 -5.1 -18.6 -3.2 - -

PEG

0.12 1.15 -0.01 0.12 -0.29 0.75 0.09 0.07 3.65 -0.63 -0.06 - -

P/B

-0.7 -1.2 -0.6 -8.8 74.2 15.3 7.0 1.1 1.1 5.6 1.7 - -

P/CF

-2.2 -2.2 -0.4 -8.6 -20.8 -8.1 -13.1 -5.2 -8.5 -22.8 -7.1 - -

ROE %

45.99 72.17 136.64 149.32 -487.04 -255.07 -68.24 -32.80 -17.33 -27.24 -35.21 - -

ROA %

-101.68 -94.24 -70.52 -40.64 -45.31 -140.68 -60.10 -30.58 -16.84 -25.38 -33.32 - -

ROCE %

34.19 55.44 115.12 -46.84 -62.75 -258.58 -69.06 -33.16 -17.26 -26.28 -30.72 - -

Current Ratio

0.3 0.4 0.7 3.7 3.2 2.2 6.2 13.7 38.1 19.4 14.4 - -

DSO

129.0 137.0 53.4 - - - - - - - - - -

DIO

- - - 2462.2 - - - - - - - - -

DPO

- - - 7931.0 - - - - - - - - -

Операционный цикл

129.0 137.0 53.4 2462.2 - - - - - - - - -

Финансовый цикл

129.0 137.0 53.4 -5468.7 - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Esperion Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.15 -0.33 0.36 -0.37 -0.46 -0.79 - -0.81 -1.05 -0.93 - -2.62 -1.67 -3.5 -3.89 -3.07 4.5 -2.84 -2.26 -2.52 -2.01 3.26 -2.24 -1.86 -1.71 -1.73 -1.44 -1.86 -1.92 -1.8 -1.29 -0.77 -0.62 -0.65 -0.58 -0.57 -0.55 -0.56 -0.49 -0.64 -0.6 -0.51 -0.63 -0.34 -19.82 -12.24 -8.12 -10.31 -9.94 -7.96 - - - -

EBITDA per Share

- - - - - -0.62 - -0.61 -0.83 -0.7 - -2.09 -1.24 -3.18 -3.56 -2.88 4.68 -2.7 -2.15 -2.41 -2.05 3.24 -2.26 -1.88 -1.73 -1.76 -1.48 -1.87 -1.93 -1.81 -1.3 -0.78 -0.63 -0.65 -0.59 -0.57 -0.55 -0.55 -0.49 -0.62 -0.6 -0.51 -0.63 -0.35 -12.1 -9.56 -6.32 -8.87 -8.76 -7.11 - - - -

ROE %

15.29 20.74 21.47 60.95 69.63 78.94 64.26 83.39 83.78 75.39 67.24 175.91 245.66 101.68 149.32 -269.86 -701.47 -843.64 -487.04 -252.42 27.24 241.22 -255.07 -194.67 -150.07 -109.98 -68.24 -65.43 -54.56 -42.99 -32.80 -24.70 -21.54 -19.72 -17.33 -19.84 -22.73 -25.33 -27.24 -33.23 -32.96 -35.39 -35.21 -15.42 -0.25 16.74 22.47 15.76 7.65 - - - - -

ROA %

-29.26 -41.14 -48.07 -82.05 -81.03 -76.29 -50.71 -81.52 -78.15 -93.72 -79.01 -108.59 -101.97 -51.12 -40.64 -39.95 -47.65 -108.21 -45.31 -58.28 -61.18 -67.78 -140.68 -112.47 -93.95 -77.67 -60.10 -58.27 -49.10 -39.22 -30.58 -23.21 -20.44 -18.91 -16.84 -19.00 -21.52 -23.77 -25.39 -31.16 -31.01 -33.40 -33.32 -58.90 -98.04 -132.50 -127.08 -89.13 -43.30 - - - - -

ROCE %

-14.26 -8.63 6.87 45.57 53.01 61.00 49.37 64.74 65.96 58.69 56.80 156.22 224.64 79.58 126.28 -268.69 -682.15 -824.97 -466.67 -247.77 17.99 236.42 -258.58 -197.74 -152.52 -111.62 -69.06 -66.06 -55.11 -43.54 -33.31 -25.11 -21.86 -19.93 -17.42 -19.84 -22.60 -25.19 -27.12 -33.24 -33.28 -32.11 -30.72 -12.36 2.17 14.86 19.37 14.15 6.92 - - - - -

Current Ratio

0.5 0.5 0.6 0.3 0.4 0.4 0.4 0.5 - 0.6 0.7 0.4 0.5 0.5 0.8 0.8 0.8 0.8 1.1 1.1 1.1 1.1 2.2 2.2 2.2 2.2 8.4 8.4 8.4 8.4 14.8 14.8 14.8 14.8 35.6 35.6 35.6 35.6 14.7 14.7 14.7 14.7 18.6 18.6 18.6 18.6 0.3 0.3 0.3 - - - - -

DSO

113.3 71.0 32.2 112.0 136.6 131.5 - 75.7 60.8 116.4 - 137.9 43.9 169.5 117.3 294.9 5.3 307.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

113.3 71.0 32.2 112.0 136.6 131.5 - 75.7 60.8 116.4 - 137.9 43.9 169.5 117.3 294.9 5.3 307.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

113.3 71.0 32.2 112.0 136.6 131.5 - 75.7 60.8 116.4 - 137.9 43.9 169.5 117.3 294.9 5.3 307.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD